SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)			1 Months Ended			3 Months Ended		9 Months Ended
	Aug. 25, 2021	Aug. 05, 2021	Oct. 31, 2021	Oct. 25, 2021	Aug. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Nov. 22, 2021	Dec. 31, 2020	Oct. 31, 2017
Accumulated deficit						$ 14,747,000		$ 14,747,000
Cash						3,631,000		3,631,000
Common stock value						2,139		2,139			$ 1,692
Gain on sale of marketable securities						$ 160,296		$ 160,296
Basic earnings per share						21,389,041	16,915,706	9,472,506	16,915,706
Business acquisition, goodwill						$ 2,188,810		$ 2,188,810			2,188,810
Phoenix Life Sciences, Inc. [Member]
Business acquisition, goodwill												$ 2,530,000
Business acquisition, Intangible assets						$ 921,000		$ 921,000			$ 123,000
XXII Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction	70,000	70,000
Sale of stock price per share		$ 3.29
Sale of Stock, Consideration Received on Transaction	$ 230,296				$ 230,296
Gain on sale of marketable securities					$ 160,296
Marketable Securities [Member]
Investment owned, shares						1,227,017		1,227,017
Subsequent Event [Member]
Escrow deposit										$ 1,100,000
Reverse Stock Split			1-for-28 reverse stock split	1-for-28 reverse stock split
Leslie Buttorff [Member]
Notes Payable, Current						$ 1,624,000		$ 1,624,000
22nd Century Group, Inc [Member]
Common stock shares hold						1,227,017		1,227,017
Common stock value						$ 3,631,000		$ 3,631,000
Quintel MC, Inc [Member]
Notes Payable, Current						$ 4,063,000.000		$ 4,063,000.000